Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-1-28
pubmed:abstractText
Despite the clinical similarities triple-negative and basal-like breast cancer are not synonymous. Indeed, not all basal-like cancers are negative for estrogen receptor, progesterone receptor and HER2 expression while triple-negative also encompasses other cancer types. P53 protein appears heterogeneously expressed in triple-negative breast cancers, suggesting that it may be associated with specific biological subgroups with a different outcome.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1465-3621
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
172-9
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features.
pubmed:affiliation
Department of Work Medicine Clinica del Lavoro L. Devoto, Section Department of Medical Statistics and Biometry G.A. Maccacaro, University of Milan, Via Vanzetti 5, 20133 Milan, Italy.
pubmed:publicationType
Journal Article, Comparative Study